[To study the effectiveness and impact on the quality of life of patients with subclinical and clinically pronounced anxiety disorder of a mobile application in combination with Adaptol therapy].

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)

Taking temgicoluril (Adaptol) for 3 months led to symptoms decrease and the quality of life and well-being improvement in patients with AD. Using the mobile application Zdorovye.ru in conjunction with drug therapy made it possible to achieve a clinical effect earlier, in 1.5 months.

Keyphrases

randomized controlled trial
systematic review
stem cells
bone marrow
cell therapy
depressive symptoms
electron transfer